Home LiteratureArticle Details
PMID: 7510883 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby DA

Abstract

Cyclooxygenase (COX) converts arachidonic acid to prostaglandin H2, which is further metabolized to prostanoids. Two isoforms of COX exist: a constitutive (COX-1) and an inducible (COX-2) enzyme. Nitric oxide is derived from L-arginine by isoforms of nitric-oxide synthase (NOS; EC 1.14.13.39): constitutive (cNOS; calcium-dependent) and inducible (iNOS; calcium-independent). Here we have investigated inducible isoforms of COX and NOS in the acute, chronic, and resolving stages of a murine air pouch model of granulomatous inflammation. COX and NOS activities were measured in skin samples in the acute phase, up to 24 h. Activities in granulomatous tissue were measured at 3, 5, 7, 14, and 21 days for the chronic and resolving stages of inflammation. COX-1 and COX-2 proteins were assessed by Western blot. COX activity in the skin increased over the first 24 h and continued to rise up to day 14. COX-2 protein rose progressively, also peaking at day 14. COX-1 protein remained unaltered throughout. The iNOS activity increased over the first 24 h in the skin, with a further major increase in the granulomatous tissue between days 3 and 7, followed by a decrease at day 14 and a further increase at day 21. The rise in COX and NOS activities in the skin during the acute phase reinforces the proinflammatory role for prostanoids and suggests one also for nitric oxide. However, in the chronic and resolving stages, a dissociation of COX and NOS activity occurred. Thus, there may be differential regulation of these enzymes, perhaps due to the changing pattern of cytokines during the inflammatory response.

MeSH Terms
Amino Acid Oxidoreductases/metabolism Animals Blotting, Western Enzyme Induction Female Granuloma/enzymology,pathology Inflammation/enzymology Isoenzymes/metabolism Mice Nitric Oxide Synthase Prostaglandin-Endoperoxide Synthases/metabolism Skin/enzymology Skin Diseases/enzymology,pathology
Chemicals
Isoenzymes Nitric Oxide Synthase Prostaglandin-Endoperoxide Synthases Amino Acid Oxidoreductases
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Vane J R
William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London, United Kingdom.
Mitchell J A
Appleton I
Tomlinson A
Bishop-Bailey D
Croxtall J
Willoughby D A
References (51)
51 references, click to expand
  1. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.
    Nat New Biol. 1971 Jun 23;231(25):232-5 PMID: 5284360
  2. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774.
    Br J Pharmacol. 1992 Nov;107(3):640-1 PMID: 1282071
  3. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  4. Control of lymphokine secretion by prostaglandins.
    Nature. 1976 Jul 29;262(5567):401-2 PMID: 958392
  5. Restoration of prostacyclin synthase in vascular smooth muscle cells after aspirin treatment: regulation by epidermal growth factor.
    J Lipid Res. 1985 Jan;26(1):54-61 PMID: 3919134
  6. Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1.
    J Immunol. 1985 Sep;135(3):1872-7 PMID: 3874907
  7. Endothelium-dependent inhibition of platelet aggregation.
    Br J Pharmacol. 1986 Jun;88(2):411-5 PMID: 3089351
  8. The VLA protein family. Characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight beta subunit.
    J Biol Chem. 1987 Mar 5;262(7):3300-9 PMID: 3546305
  9. Inflammation and the mechanism of action of anti-inflammatory drugs.
    FASEB J. 1987 Aug;1(2):89-96 PMID: 3111928
  10. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.
    Lancet. 1987 Nov 7;2(8567):1057-8 PMID: 2889967
  11. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells.
    Proc Natl Acad Sci U S A. 1988 Apr;85(8):2800-4 PMID: 3258664
  12. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
    J Immunol. 1988 Oct 1;141(7):2407-12 PMID: 3139757
  13. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
    Eur J Immunol. 1988 Oct;18(10):1587-92 PMID: 3142779
  14. Prostaglandin E2-dependent induction of granulocyte-macrophage colony-stimulating factor secretion by cloned murine helper T cells.
    J Immunol. 1989 Feb 1;142(3):813-8 PMID: 2521509
  15. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells.
    J Leukoc Biol. 1993 Feb;53(2):165-72 PMID: 8445328
  16. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.
    Br J Pharmacol. 1993 Mar;108(3):786-92 PMID: 7682137
  17. Nitric oxide mediates interleukin-1-induced prostaglandin E2 production by vascular smooth muscle cells.
    Biochem Biophys Res Commun. 1993 Jul 15;194(1):420-4 PMID: 8392840
  18. Nitric oxide activates cyclooxygenase enzymes.
    Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7240-4 PMID: 7688473
  19. Control of the circulation by endothelial mediators. Inaugural G.B. West Memorial Lecture.
    Int Arch Allergy Immunol. 1993;101(4):333-45 PMID: 8353456
  20. Prostaglandins as modulators rather than mediators of inflammation.
    J Lipid Mediat. 1993 Mar-Apr;6(1-3):275-86 PMID: 8395250
  21. Inflammation, prostaglandins, and loss of function.
    J Lipid Mediat. 1993 Mar-Apr;6(1-3):287-93 PMID: 8357986
  22. Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes.
    Lab Invest. 1993 Oct;69(4):405-14 PMID: 8231109
  23. Modulation of adjuvant arthritis by endogenous nitric oxide.
    Br J Pharmacol. 1993 Oct;110(2):701-6 PMID: 8242242
  24. Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat.
    Br J Pharmacol. 1993 Oct;110(2):896-902 PMID: 8242264
  25. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases.
    Proc Natl Acad Sci U S A. 1989 Mar;86(5):1657-61 PMID: 2493647
  26. Anti-inflammatory effects of endothelin-1.
    J Cardiovasc Pharmacol. 1989;13 Suppl 5:S218-9 PMID: 2473318
  27. Tumor necrosis factor causes amplification of arachidonic acid metabolism in response to interleukin 1, bradykinin, and other agonists.
    J Cell Physiol. 1989 Oct;141(1):85-9 PMID: 2550484
  28. Regulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by platelet-derived growth factor.
    J Biol Chem. 1989 Oct 15;264(29):17379-83 PMID: 2507542
  29. Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclo-oxygenase/PGE isomerase.
    Br J Pharmacol. 1989 Dec;98(4):1287-95 PMID: 2514948
  30. Cyclooxygenase inhibition enhances rat interleukin 1 beta-induced growth of rat mesangial cells in culture.
    Am J Physiol. 1990 Sep;259(3 Pt 2):F419-24 PMID: 2118724
  31. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway.
    Am J Physiol. 1990 Oct;259(4 Pt 2):H1038-43 PMID: 2221111
  32. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo.
    Eur J Pharmacol. 1990 Jul 17;182(3):591-5 PMID: 2226626
  33. Prostaglandins antagonize fibroblast proliferation stimulated by tumor necrosis factor.
    Biochem Biophys Res Commun. 1991 Jan 31;174(2):758-66 PMID: 1993070
  34. Evidence that endogenous nitric oxide modulates oedema formation induced by substance P.
    Eur J Pharmacol. 1990 Dec 4;191(3):481-4 PMID: 1707819
  35. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway.
    J Surg Res. 1991 Apr;50(4):403-9 PMID: 2020192
  36. Nitric oxide: an endogenous modulator of leukocyte adhesion.
    Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4651-5 PMID: 1675786
  37. Tissue injury caused by deposition of immune complexes is L-arginine dependent.
    Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6338-42 PMID: 1648737
  38. Analytical procedures for a cryptic messenger RNA that mediates translational control of prostaglandin synthase by glucocorticoids.
    Anal Biochem. 1991 Jul;196(1):11-8 PMID: 1909509
  39. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide.
    J Immunol. 1991 Dec 1;147(11):3915-20 PMID: 1658153
  40. Isoforms of nitric oxide synthase. Characterization and purification from different cell types.
    Biochem Pharmacol. 1991 Oct 24;42(10):1849-57 PMID: 1720618
  41. Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle.
    Br J Pharmacol. 1991 Oct;104(2):289-91 PMID: 1724623
  42. Molecular regulation of tumor necrosis factor-alpha and lymphotoxin production in T cells. Inhibition by prostaglandin E2.
    J Biol Chem. 1992 May 5;267(13):9443-9 PMID: 1533632
  43. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform.
    Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6348-52 PMID: 1378626
  44. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.
    Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6711-5 PMID: 1379716
  45. Protective and pathological roles of nitric oxide in endotoxin shock.
    Cardiovasc Res. 1992 Jan;26(1):48-57 PMID: 1516112
  46. Nitric oxide as a secretory product of mammalian cells.
    FASEB J. 1992 Sep;6(12):3051-64 PMID: 1381691
  47. Regulation of synovial cell growth: basic fibroblast growth factor synergizes with interleukin 1 beta stimulating phospholipase A2 enzyme activity, phospholipase A2 activating protein production and release of prostaglandin E2 by rheumatoid arthritis synovial cells in culture.
    Cytokine. 1992 Sep;4(5):377-84 PMID: 1420999
  48. The induction of nitric oxide synthase activity is inhibited by TGF-beta 1, PDGFAB and PDGFBB in vascular smooth muscle cells.
    Eur J Pharmacol. 1992 Jun 17;216(3):379-83 PMID: 1385162
  49. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase.
    J Clin Invest. 1992 Nov;90(5):2092-6 PMID: 1385480
  50. Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. A pharmacologic and immunohistochemical study.
    Lab Invest. 1992 Dec;67(6):703-10 PMID: 1460861
  51. Heberden Oration, 1974. Human arthritis applied to animal models. Towards a better therapy.
    Ann Rheum Dis. 1975 Dec;34(6):471-8 PMID: 176957
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1994-03-15
Pages
2046-50
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC43306
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]